Iovance Biotherapeutics Inc
NASDAQ:IOVA

Watchlist Manager
Iovance Biotherapeutics Inc Logo
Iovance Biotherapeutics Inc
NASDAQ:IOVA
Watchlist
Price: 7.3601 USD -0.27%
Market Cap: 2.2B USD
Have any thoughts about
Iovance Biotherapeutics Inc?
Write Note

Cash Flow Statement

Cash Flow Statement
Iovance Biotherapeutics Inc

Rotate your device to view
Cash Flow Statement
Currency: USD
Sep-2014 Dec-2014 Mar-2015 Jun-2015 Sep-2015 Dec-2015 Mar-2016 Jun-2016 Sep-2016 Dec-2016 Mar-2017 Jun-2017 Sep-2017 Dec-2017 Mar-2018 Jun-2018 Sep-2018 Dec-2018 Mar-2019 Jun-2019 Sep-2019 Dec-2019 Mar-2020 Jun-2020 Sep-2020 Dec-2020 Mar-2021 Jun-2021 Sep-2021 Dec-2021 Mar-2022 Jun-2022 Sep-2022 Dec-2022 Mar-2023 Jun-2023 Sep-2023 Dec-2023 Mar-2024 Jun-2024 Sep-2024
Operating Cash Flow
Net Income
(19)
(12)
(15)
(19)
(24)
(28)
(29)
(34)
(46)
(53)
(67)
(79)
(82)
(92)
(98)
(105)
(117)
(124)
(134)
(151)
(167)
(198)
(230)
(246)
(255)
(260)
(265)
(284)
(311)
(342)
(358)
(376)
(390)
(396)
(412)
(419)
(433)
(444)
(450)
(440)
(410)
Depreciation & Amortization
0
0
0
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
2
3
5
6
8
9
10
13
17
21
26
30
32
Stock-Based Compensation
0
4
0
0
0
9
10
16
24
19
20
18
12
12
13
15
18
20
22
23
24
24
28
32
36
41
48
52
61
70
75
83
84
84
77
72
68
63
64
78
0
Other Non-Cash Items
13
4
4
5
7
9
9
12
18
19
20
18
12
12
13
15
17
19
20
22
25
27
33
38
43
50
60
65
78
87
92
101
98
97
88
82
77
71
70
81
94
Cash Taxes Paid
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2
3
5
6
6
Cash Interest Paid
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Change in Working Capital
(2)
(1)
1
0
1
(0)
(0)
2
(1)
0
(2)
(1)
(1)
0
6
5
8
3
0
6
4
10
1
8
14
3
2
(2)
(5)
25
23
6
15
(3)
(5)
(11)
(17)
(10)
(31)
(59)
(79)
Cash from Operating Activities
(8)
N/A
(9)
-14%
(10)
-14%
(13)
-32%
(15)
-16%
(18)
-22%
(19)
-6%
(19)
+4%
(27)
-45%
(33)
-21%
(47)
-44%
(61)
-29%
(70)
-15%
(79)
-13%
(78)
+1%
(84)
-8%
(91)
-8%
(101)
-12%
(112)
-11%
(122)
-9%
(137)
-12%
(159)
-16%
(195)
-23%
(198)
-1%
(196)
+1%
(205)
-5%
(202)
+1%
(220)
-9%
(237)
-8%
(228)
+4%
(239)
-5%
(263)
-10%
(269)
-2%
(293)
-9%
(319)
-9%
(335)
-5%
(356)
-6%
(362)
-2%
(384)
-6%
(389)
-1%
(364)
+6%
Investing Cash Flow
Capital Expenditures
(0)
(2)
(2)
(3)
(2)
(1)
(0)
(0)
(1)
(2)
(2)
(2)
(2)
(1)
(0)
(1)
(1)
(1)
(2)
(3)
(4)
(7)
(7)
(10)
(27)
(47)
(57)
(62)
(53)
(38)
(38)
(33)
(25)
(20)
(15)
(20)
(22)
(22)
(21)
(12)
(10)
Other Items
0
0
0
(100)
(79)
(90)
(80)
9
(27)
10
20
56
86
60
40
(15)
(179)
(385)
(383)
(293)
(139)
97
196
(283)
(323)
(271)
(284)
(15)
43
38
48
298
350
277
338
90
(60)
(133)
(399)
(211)
(182)
Cash from Investing Activities
(0)
N/A
(2)
-835%
(2)
-49%
(102)
-4 215%
(82)
+20%
(91)
-11%
(80)
+12%
9
N/A
(28)
N/A
9
N/A
18
+100%
54
+201%
84
+58%
59
-30%
40
-32%
(16)
N/A
(180)
-1 026%
(386)
-115%
(385)
+0%
(296)
+23%
(143)
+52%
90
N/A
189
+110%
(293)
N/A
(350)
-19%
(318)
+9%
(341)
-7%
(76)
+78%
(10)
+86%
0
N/A
9
+7 162%
264
+2 700%
325
+23%
256
-21%
323
+26%
71
-78%
(82)
N/A
(155)
-89%
(420)
-171%
(223)
+47%
(193)
+14%
Financing Cash Flow
Net Issuance of Common Stock
25
35
106
109
110
78
8
99
97
98
98
2
58
60
229
232
188
425
255
255
244
6
10
576
576
577
622
217
237
238
190
27
6
193
451
452
655
466
404
556
401
Net Issuance of Debt
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
1
1
1
0
0
0
0
0
0
0
0
0
0
0
Other
0
0
0
0
0
0
0
(0)
(0)
(1)
(1)
(1)
(1)
(1)
(1)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
0
0
0
0
0
(3)
(3)
(3)
(5)
(2)
(3)
(3)
(6)
(6)
(12)
Cash from Financing Activities
25
N/A
35
+43%
106
+198%
109
+4%
110
+1%
78
-29%
8
-90%
98
+1 182%
97
-1%
97
0%
97
+0%
0
-100%
56
+12 627%
59
+5%
228
+288%
232
+2%
188
-19%
424
+126%
255
-40%
255
+0%
243
-4%
6
-97%
10
+62%
575
+5 674%
576
+0%
576
+0%
623
+8%
218
-65%
238
+9%
239
+0%
190
-20%
24
-87%
4
-85%
190
+5 012%
447
+135%
450
+1%
653
+45%
463
-29%
398
-14%
550
+38%
389
-29%
Change in Cash
Effect of Foreign Exchange Rates
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
(4)
(6)
(3)
(3)
0
4
Net Change in Cash
17
N/A
25
+48%
93
+270%
(6)
N/A
14
N/A
(31)
N/A
(92)
-195%
88
N/A
42
-52%
73
+73%
68
-7%
(7)
N/A
70
N/A
39
-45%
190
+391%
132
-31%
(83)
N/A
(63)
+23%
(243)
-284%
(164)
+33%
(36)
+78%
(63)
-72%
4
N/A
84
+2 005%
30
-65%
53
+81%
80
+50%
(77)
N/A
(9)
+88%
11
N/A
(40)
N/A
26
N/A
60
+134%
154
+156%
451
+193%
182
-60%
209
+15%
(57)
N/A
(409)
-620%
(61)
+85%
(164)
-167%
Free Cash Flow
Free Cash Flow
(8)
N/A
(10)
-32%
(12)
-19%
(16)
-27%
(18)
-13%
(20)
-11%
(20)
-2%
(19)
+4%
(28)
-47%
(34)
-22%
(49)
-44%
(63)
-28%
(72)
-14%
(80)
-11%
(78)
+2%
(85)
-9%
(92)
-8%
(102)
-12%
(114)
-12%
(125)
-10%
(140)
-12%
(166)
-18%
(202)
-22%
(208)
-3%
(223)
-7%
(252)
-13%
(259)
-3%
(281)
-8%
(290)
-3%
(266)
+8%
(278)
-5%
(296)
-7%
(294)
+1%
(313)
-7%
(333)
-6%
(355)
-6%
(377)
-6%
(384)
-2%
(405)
-5%
(400)
+1%
(374)
+7%

See Also

Discover More